SCHEMBL6807705

SCHEMBL6807705

COc1ccc(/C(=C\OC(F)F)C(=O)NCCc2ccc(O)c(OC)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.48
NOX4 Q9NPH5 1/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
TYR P14679 1/20 0.48
ACHE P22303 1/20 0.48
HDAC1 Q13547 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
MTNR1A P48039 1/20 0.47
MTNR1B P49286 1/20 0.47
ALDH1A1 P00352 3/20 0.46
HPGD P15428 1/20 0.46
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
CAPN1 P07384 1/20 0.45
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
ALOX5 P09917 1/20 0.45
OR51E2 Q9H255 1/20 0.45
CA1 P00915 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6807707 1.00 MAPT (0.48) MAPTNOX4MEN1KMT2ATYR
SCHEMBL6802209 0.92 NOX4 (0.48) MAPTNOX4TYRACHEHDAC1
SCHEMBL6802206 0.92 NOX4 (0.48) MAPTNOX4TYRACHEHDAC1
SCHEMBL6803651 0.92 NOX4 (0.48) NOX4KMT2ATYRACHEHDAC1
SCHEMBL6797880 0.92 ALDH1A1 (0.52) MAPTNOX4KMT2ATYRACHE
SCHEMBL6797885 0.92 ALDH1A1 (0.52) MAPTNOX4KMT2ATYRACHE
SCHEMBL6803649 0.92 NOX4 (0.48) NOX4KMT2ATYRACHEHDAC1
SCHEMBL6801546 0.92 MAPT (0.58) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL6801543 0.92 MAPT (0.58) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL6798746 0.91 GAA (0.53) NOX4TYRACHEHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762321-B2 SUCH AS N-(2-(3,4-DIMETHOXYPHENYL)ETHYL)-3-DIFLUOROMETHOXY-2-(4 -METHYLPHENYL)ACRYLAMIDE; FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-07-13 US disclosed
US-20030195354-A1 Amide compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-16 US disclosed
EP-1295868-A1 AMIDE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195354-A1 Amide compounds and use thereof CBR1, CBR3, NAT1 MAPT 3676/4885NOX4 331/4885MEN1 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.